UCLA has received $27.2 million from the National Institutes of Health to spearhead the new phase of an initiative to enhance the diversity of the U.S.'s biomedical workforce. Principal investigators of the initiative include Fielding School professors Teresa Seeman and Steven Wallace, as well as senior leader Catherine Crespi.

Research reported at the Alzheimer’s Association International Conference (AAIC) 2019 in Los Angeles identified a number of differences in the progression and risk of Alzheimer’s disease between women and men.

Most studies have focused on older women, but breast cancer can take decades to develop, and children may be most susceptible to the effects of diet, chemicals and other factors.

UCLA Fielding School of Public Health faculty members Ronald Hays, Steve Horvath, Michael Jerrett, André Nel, Beate Ritz and Marc Suchard have been named to Clarivate Analytics' annual list of highly cited researchers.

Anne Rimoin, associate professor of epidemiology at the UCLA Fielding School of Public Health, has been appointed director of the Fielding School’s Center for Global and Immigrant Health.

In March 2018, the National Institute on Drug Abuse (NIDA) awarded researchers at the UCLA Fielding School of Public Health $9.5 million over five years to continue their work on possible connections between substance abuse and HIV infection. The work, which has officially begun this June, is a continuation of a study that launched in 2013 with a $7 million NIDA grant.

Calls for a far-reaching and verifiable research program on the incidence and mortality of cancer in China’s Jiangsu province have been answered.

UCLA-led study holds promise for development of vaccines and therapeutic drugs to fight the virus.

The National Institute on Drug Abuse has awarded $5 million to researchers at UCLA to develop a resource and data center for millions of pieces of research, lab samples, statistics and other data aimed at boosting research into the effects of substance abuse on HIV/AIDS.